cholesterol emboli syndrome
FREE subscriptions for doctors and students... click here
You have 3 more open access pages.
The cholesterol emboli syndrome is a multi-system disease which may complicate:
- arteriography
- thrombolysis
- anticoagulation
- vascular surgery
The characteristic clinical triad is:
- livedo reticularis
- renal failure
- eosinophilia
Multiple treatment regimens have been generally unsuccessful in altering the course of the disease process. The most significant impact on the disease can be made by its prevention
- thrombolytic and anticoagulant treatments are not indicated and only supportive care for such symptoms as hypertension, ulceration, and gangrene is advocated
- prognosis depends on the extent of the systemic disease and a high rate of mortality (75–80%) is recorded due to multifactorial, cardiac, and renal aetiologies
-
prognosis is poor with high mortality and the treatment is only supportive
Reference:
- Heart 2003;89:e17 (http://www.heartjnl.com/cgi/content/full/89/5/e17)
- Scolari F, Ravani P, Gaggi R, et al. (July 2007). The challenge of diagnosing atheroembolic renal disease: clinical features and prognostic factors. Circulation 116 (3): 298–304.
Last reviewed 01/2018
Links: